157 related articles for article (PubMed ID: 20083263)
1. Editorial comment.
Pantuck AJ
J Urol; 2010 Mar; 183(3):914. PubMed ID: 20083263
[No Abstract] [Full Text] [Related]
2. Editorial comment.
Klatte T
J Urol; 2009 Dec; 182(6):2606. PubMed ID: 19836796
[No Abstract] [Full Text] [Related]
3. Editorial comment.
Kattan MW
Urology; 2010 Jun; 75(6):1371; author reply 1371-2. PubMed ID: 20513496
[No Abstract] [Full Text] [Related]
4. Editorial comment.
Uzzo RG
J Urol; 2009 Nov; 182(5):2171. PubMed ID: 19758642
[No Abstract] [Full Text] [Related]
5. Editorial comment.
Pomara G; Francesca F
Urology; 2011 May; 77(5):1146; author reply 1146-7. PubMed ID: 21539964
[No Abstract] [Full Text] [Related]
6. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
Eggener S
Eur Urol; 2010 Mar; 57(3):472. PubMed ID: 19359087
[No Abstract] [Full Text] [Related]
7. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
Russo P
Eur Urol; 2010 Mar; 57(3):472-3. PubMed ID: 19359086
[No Abstract] [Full Text] [Related]
8. Editorial comment on: hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinoma and oncocytoma have excellent oncologic outcomes.
Becker F
Eur Urol; 2010 Apr; 57(4):666. PubMed ID: 19477584
[No Abstract] [Full Text] [Related]
9. Editorial comment on: hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.
Bex A
Eur Urol; 2010 Apr; 57(4):665. PubMed ID: 19477585
[No Abstract] [Full Text] [Related]
10. Editorial comment on: Prognosis value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Russo P
Eur Urol; 2009 Feb; 55(2):459. PubMed ID: 18692952
[No Abstract] [Full Text] [Related]
11. Editorial comment.
Russo P
Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
[No Abstract] [Full Text] [Related]
12. Editorial comment.
Wood CG
J Urol; 2010 Apr; 183(4):1315-6; discussion 1316. PubMed ID: 20171660
[No Abstract] [Full Text] [Related]
13. Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma.
Katz MD; Serrano MF; Grubb RL; Skolarus TA; Gao F; Humphrey PA; Kibel AS
J Urol; 2010 Mar; 183(3):909-14. PubMed ID: 20083280
[TBL] [Abstract][Full Text] [Related]
14. Editorial comment on: Prognostic value of capsular invasion for localized clear-cell renal cell carcinoma.
Volpe A
Eur Urol; 2009 Dec; 56(6):1012. PubMed ID: 19135777
[No Abstract] [Full Text] [Related]
15. Editorial comment.
Russo P
Urology; 2009 May; 73(5):1082. PubMed ID: 19394510
[No Abstract] [Full Text] [Related]
16. Editorial comment on: Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
Kirkali Z
Eur Urol; 2009 Feb; 55(2):460. PubMed ID: 18692949
[No Abstract] [Full Text] [Related]
17. Editorial comment.
Campbell SC; Lane BR
J Urol; 2010 Feb; 183(2):485; discussion 485. PubMed ID: 20006871
[No Abstract] [Full Text] [Related]
18. Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Blute ML
Eur Urol; 2010 Jan; 57(1):110-1. PubMed ID: 19062158
[No Abstract] [Full Text] [Related]
19. Editorial comment on: External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
Giannarini G; Autorino R
Eur Urol; 2010 Jan; 57(1):109-10. PubMed ID: 19062156
[No Abstract] [Full Text] [Related]
20. [Pathology of benign and malignant renal cell tumors].
Thoenes W; Störkel S
Urologe A; 1991 Nov; 30(6):W41-50. PubMed ID: 1771712
[No Abstract] [Full Text] [Related]
[Next] [New Search]
